We investigated the effect of angiotensin II on endothelin-1 secretion in vitro and in vivo. In vivo, angiotensin II was given intravenously to 23 essential hypertensive and 8 control subjects according to different protocols: Study A, 1.0 ngċmin-1ċkg-1 and 3.0 ngċmin-1ċkg-1 angiotensin II for 30 min each; Study B, 1.0 ngċmin-1ċkg-1 and 3.0 ngċmin-1ċkg-1 angiotensin II for 120 min each; Study C, 3.0 ngċmin-1ċkg-1 angiotensin II for 30 min followed by a dose increment of 3.0 ngċmin-1ċkg-1 every 30 min until mean blood pressure levels increased by 25 mmHg; Study D, 1.0 ngċmin-1ċkg-1 followed by 3.0 ngċmin-1ċkg-1 angiotensin II for 60 min each on two different NaCl diets (either 20 mmol NaCl/day or 220 mmol NaCl/day, both for 1 week). In all in vivo studies neither plasma nor urine endothelin-1 levels changed with angiotensin II infusion. In contrast, angiotensin II (10-9, 10-8, 10-7 mol/l) stimulated endothelin-1 secretion from cultured human vascular endothelial cells derived from umbilical cord veins in a time- and dose-dependent manner. The in vitro angiotensin II effects were abolished by candesartan cilexetil, an inhibitor of the membrane-bound AT1 receptor, and also by actinomycin D, an RNA synthesis inhibitor, and cycloheximide, a protein synthesis inhibitor, indicating that endothelin-1 release depended on AT1 receptor subtype and de novo protein synthesis. Our findings indicate that angiotensin II regulates endothelin-1 release by cultured endothelial cells through an AT1 receptor-dependent pathway, but does not influence circulating endothelin-1 levels in vivo.
Skip Nav Destination
Article navigation
Research Article|
March 01 1999
Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels Available to Purchase
Claudio FERRI;
1University of Rome ‘La Sapienza’, Andrea Cesalpino Foundation, Rome 00161, Italy
Correspondence: Dr C. Ferri.
Search for other works by this author on:
Giovambattista DESIDERI;
Giovambattista DESIDERI
1University of Rome ‘La Sapienza’, Andrea Cesalpino Foundation, Rome 00161, Italy
Search for other works by this author on:
Roberta BALDONCINI;
Roberta BALDONCINI
1University of Rome ‘La Sapienza’, Andrea Cesalpino Foundation, Rome 00161, Italy
Search for other works by this author on:
Cesare BELLINI;
Cesare BELLINI
*Department of Experimental Medicine, University of L'Aquila, L'Aquila 67100, Italy
Search for other works by this author on:
Marco VALENTI;
Marco VALENTI
†Department of Internal Medicine, University of L'Aquila, L'Aquila 67100, Italy
Search for other works by this author on:
Anna SANTUCCI;
Anna SANTUCCI
†Department of Internal Medicine, University of L'Aquila, L'Aquila 67100, Italy
Search for other works by this author on:
Giancarlo DE MATTIA
Giancarlo DE MATTIA
1University of Rome ‘La Sapienza’, Andrea Cesalpino Foundation, Rome 00161, Italy
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 20 1998
Revision Received:
September 03 1998
Accepted:
October 07 1998
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 1999
1999
Clin Sci (Lond) (1999) 96 (3): 261–270.
Article history
Received:
May 20 1998
Revision Received:
September 03 1998
Accepted:
October 07 1998
Citation
Claudio FERRI, Giovambattista DESIDERI, Roberta BALDONCINI, Cesare BELLINI, Marco VALENTI, Anna SANTUCCI, Giancarlo DE MATTIA; Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels. Clin Sci (Lond) 1 March 1999; 96 (3): 261–270. doi: https://doi.org/10.1042/cs0960261
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |